Serotype 1 and 8 pneumococci evade sensing by inflammasomes in human lung tissue

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Fatykhova, Diana ^a   Rabes, Anne ^a   Machnik, Christoph ^a   Guruprasad, Kunchur ^b   Pache, Florence ^a   Berg, Johanna ^a   Toennies, Mario ^c   Bauer, Torsten T ^c   Schneider, Paul ^d   Schimek, Maria ^e   Eggeling, Stephan ^e   Mitchell, Timothy J ^f   Mitchell, Andrea M ^f   Hilker, Rolf ^g   Hain, Torsten ^g   Suttorp, Norbert ^a   Hippenstiel, Stefan ^a   Hocke, Andreas C ^a   Opitz, Bastian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^c HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^d DRK Clinics   (Germany)

^e VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; CYTOKINE; INFLAMMASOME; INTERLEUKIN 1BETA; PNEUMOLYSIN; VIRULENCE FACTOR; BACTERIAL PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE STATUS; INNATE IMMUNITY; LOWER RESPIRATORY TRACT; LUNG PARENCHYMA; MORBIDITY; MORTALITY; PNEUMOCOCCAL INFECTION; SEROTYPE; SEROTYPE 2; SEROTYPE 3; SEROTYPE 6B; SEROTYPE 9N; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; BIOSYNTHESIS; CLASSIFICATION; CYTOLOGY; HEMOLYSIS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE;

BACTERIAL PROTEINS; CASPASE 1; HEMOLYSIS; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; LUNG; SPECIES SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 84943279632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137108     Document Type: Article

References (53)

1. Kadioglu A, Weiser JN, Paton JC, Andrew PW (2008) The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6:288-301. doi: 10.1038/nrmicro1871 PMID: 18340341
2. Koppe U, Suttorp N, Opitz B (2012) Recognition of Streptococcus pneumoniae by the innate immune system. Cell Microbiol 14:460-466. doi: 10.1111/j.1462-5822.2011.01746.x PMID: 22212419
3. Van Der Poll T, Opal SM (2009) Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374:1543-1556. doi: 10.1016/S0140-6736 (09) 61114-4 PMID: 19880020
4. Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, et al. (2009) Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 6:e1000081. doi: 10.1371/journal.pmed.1000081 PMID: 19468297
5. Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, et al. (2010) Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 51:692-699. doi: 10.1086/655828 PMID: 20715907
6. Lujan M, Gallego M, Belmonte Y, Fontanals D, Valles J, et al. (2010) Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia. Eur Respir J 36:1073-1079. doi: 10. 1183/09031936.00176309 PMID: 20150202
7. Sjostrom K, Spindler C, Ortqvist A, Kalin M, Sandgren A, et al. (2006) Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 42:451-459. PMID: 16421787
8. Henriques Normark B, Kalin M, Ortqvist A, Akerlund T, Liljequist BO, et al. (2001) Dynamics of penicillinsusceptible clones in invasive pneumococcal disease. J Infect Dis 184:861-869. PMID: 11550126
9. Kirkham LA, Jefferies JM, Kerr AR, Jing Y, Clarke SC, et al. (2006) Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin. J Clin Microbiol 44:151-159. PMID: 16390963
10. Le Hello S, Watson M, Levy M, Marcon S, Brown M, et al. (2010) Invasive serotype 1 Streptococcus pneumoniae outbreaks in the South Pacific from 2000 to 2007. J Clin Microbiol 48:2968-2971. doi: 10. 1128/JCM.01615-09 PMID: 20534799
11. Staples M, Graham RM, Jennison AV, Ariotti L, Hicks V, et al. (2015) Molecular characterization of an Australian serotype 1 Streptococcus pneumoniae outbreak. Epidemiol Infect 143:325-333. doi: 10. 1017/S0950268814000648 PMID: 24666470
12. Lamb KE, Flasche S, Diggle M, Inverarity D, Greenhalgh D, et al. (2014) Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010. Vaccine 32:4356-4363. doi: 10.1016/j.vaccine.2013.05.079 PMID: 23806244
13. Marimon JM, Ercibengoa M, Alonso M, Zubizarreta M, Perez-Trallero E (2009) Clonal structure and 21-year evolution of Streptococcus pneumoniae serotype 1 isolates in northern Spain. Clin Microbiol Infect 15:875-877. doi: 10.1111/j.1469-0691.2009.02883.x PMID: 19702591
14. Mitchell AM, Mitchell TJ (2010) Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect 16:411-418. doi: 10.1111/j.1469-0691.2010.03183.x PMID: 20132250
15. Gilbert RJ, Jimenez JL, Chen S, Tickle IJ, Rossjohn J, et al. (1999) Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97:647-655. PMID: 10367893
16. Sonnen AF, Plitzko JM, Gilbert RJ (2014) Incomplete pneumolysin oligomers form membrane pores. Open Biol 4:140044. doi: 10.1098/rsob.140044 PMID: 24759615
17. Shak JR, Ludewick HP, Howery KE, Sakai F, Yi H, et al. (2013) Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. MBio 4:e00655-00613. doi: 10.1128/mBio. 00655-13 PMID: 24023386
18. Kadioglu A, Taylor S, Iannelli F, Pozzi G, Mitchell TJ, et al. (2002) Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect Immun 70:2886-2890. PMID: 12010976
19. Rubins JB, Charboneau D, Paton JC, Mitchell TJ, Andrew PW, et al. (1995) Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest 95:142-150. PMID: 7814608
20. Canvin JR, Marvin AP, Sivakumaran M, Paton JC, Boulnois GJ, et al. (1995) The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis 172:119-123. PMID: 7797901
21. Jefferies JM, Johnston CH, Kirkham LA, Cowan GJ, Ross KS, et al. (2007) Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis 196:936-944. PMID: 17703426
22. Lock RA, Zhang QY, Berry AM, Paton JC (1996) Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin. Microb Pathog 21:71-83. PMID: 8844651
23. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, et al. (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6:e1001191. doi: 10.1371/journal.ppat.1001191 PMID: 21085613
24. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, et al. (2011) The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187:434-440. doi: 10.4049/jimmunol.1003143 PMID: 21646297
25. Fang R, Tsuchiya K, Kawamura I, Shen Y, Hara H, et al. (2011) Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J Immunol 187:4890-4899. doi: 10.4049/jimmunol.1100381 PMID: 21957143
26. Hoegen T, Tremel N, Klein M, Angele B, Wagner H, et al. (2011) The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol 187:5440-5451. doi: 10.4049/jimmunol.1100790 PMID: 22003197
27. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140:821-832. doi: 10.1016/j.cell.2010.01. 040 PMID: 20303873
28. Opitz B, Van Laak V, Eitel J, Suttorp N (2010) Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 181:1294-1309. doi: 10.1164/rccm.200909-1427SO PMID: 20167850
29. Rijneveld AW, Florquin S, Branger J, Speelman P, Van Deventer SJ, et al. (2001) TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol 167:5240-5246. PMID: 11673538
30. Lauw FN, Branger J, Florquin S, Speelman P, Van Deventer SJ, et al. (2002) IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J Immunol 168:372-378. PMID: 11751983
31. Noske N, Kammerer U, Rohde M, Hammerschmidt S (2009) Pneumococcal interaction with human dendritic cells: phagocytosis, survival, and induced adaptive immune response are manipulated by PavA. J Immunol 183:1952-1963. doi: 10.4049/jimmunol.0804383 PMID: 19570831
32. Pracht D, Elm C, Gerber J, Bergmann S, Rohde M, et al. (2005) PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun 73:2680-2689. PMID: 15845469
33. Eitel J, Meixenberger K, Van Laak C, Orlovski C, Hocke A, et al. (2012) Rac1 regulates the NLRP3 inflammasome which mediates IL-1beta production in Chlamydophila pneumoniae infected human mononuclear cells. PLoS One 7:e30379. doi: 10.1371/journal.pone.0030379 PMID: 22276187
34. Szymanski KV, Toennies M, Becher A, Fatykhova D, N'Guessan PD, et al. (2012) Streptococcus pneumoniaeinduced regulation of cyclooxygenase-2 in human lung tissue. Eur Respir J 40:1458-1467. doi: 10.1183/09031936.00186911 PMID: 22441740
35. Weinheimer VK, Becher A, Tonnies M, Holland G, Knepper J, et al. (2012) Influenza A viruses target type II pneumocytes in the human lung. J Infect Dis 206:1685-1694. doi: 10.1093/infdis/jis455 PMID: 22829640
36. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5: Unit 5 6.
37. Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW (1997) Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 89:685-692. PMID: 9182756
38. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, et al. (2012) SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455-477. doi: 10.1089/cmb.2012.0021 PMID: 22506599
39. Husemann P, Stoye J (2010) r2cat: synteny plots and comparative assembly. Bioinformatics 26:570-571. doi: 10.1093/bioinformatics/btp690 PMID: 20015948
40. Meyer F, Goesmann A, McHardy AC, Bartels D, Bekel T, et al. (2003) GenDB-an open source genome annotation system for prokaryote genomes. Nucleic Acids Res 31:2187-2195. PMID: 12682369
41. Tilley SJ, Orlova EV, Gilbert RJ, Andrew PW, Saibil HR (2005) Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 121:247-256. PMID: 15851031
42. Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, et al. (2009) Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187:61-70. doi: 10.1083/jcb.200903124 PMID: 19805629
43. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136-140. doi: 10.1038/ni.1831 PMID: 20023662
44. Knepper J, Schierhorn KL, Becher A, Budt M, Tonnies M, et al. (2013) The novel human influenza A (H7N9) virus is naturally adapted to efficient growth in human lung tissue. MBio 4:e00601-00613. doi: 10.1128/mBio.00601-13 PMID: 24105764
45. Hocke AC, Becher A, Knepper J, Peter A, Holland G, et al. (2013) Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs. Am J Respir Crit Care Med 188:882-886. doi: 10.1164/rccm.201305-0954LE PMID: 24083868
46. Bewley MA, Naughton M, Preston J, Mitchell A, Holmes A, et al. (2014) Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation. MBio 5:e01710-01714. doi: 10.1128/mBio.01710-14 PMID: 25293758
47. Lemon JK, Weiser JN (2015) Degradation products of the extracellular pathogen Streptococcus pneumoniae access the cytosol via its pore-forming toxin. MBio 6.
48. Harvey RM, Hughes CE, Paton AW, Trappetti C, Tweten RK, et al. (2014) The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent. PLoS One 9:e103625. doi: 10.1371/journal.pone.0103625 PMID: 25105894
49. Karlstrom A, Heston SM, Boyd KL, Tuomanen EI, McCullers JA (2011) Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. J Infect Dis 204:1358-1366. doi: 10.1093/infdis/jir522 PMID: 21900488
50. Koppe U, Hogner K, Doehn JM, Muller HC, Witzenrath M, et al. (2012) Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs. J Immunol 188:811-817. doi: 10.4049/jimmunol.1004143 PMID: 22156592
51. Davis KM, Nakamura S, Weiser JN (2011) Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 121:3666-3676. doi: 10.1172/JCI57761 PMID: 21841315
52. Opitz B, Puschel A, Schmeck B, Hocke AC, Rosseau S, et al. (2004) Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279:36426-36432. PMID: 15215247
53. Rabes A, Zimmermann S, Reppe K, Lang R, Seeberger PH, et al. (2015) The C-type lectin receptor Mincle binds to Streptococcus pneumoniae but plays a limited role in the anti-pneumococcal innate immune response. PLoS One 10:e0117022. doi: 10.1371/journal.pone.0117022 PMID: 25658823